Journal
BIOMETALS
Volume 23, Issue 3, Pages 399-409Publisher
SPRINGER
DOI: 10.1007/s10534-010-9331-3
Keywords
Bovine lactoferrin; Chemoprevention; Colorectal cancer
Categories
Ask authors/readers for more resources
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and, despite improved colonoscopic screening, CRC is a leading cause of death from cancer. Administration of bovine lactoferrin (bLF) suppresses carcinogenesis in the colon and other organs of test animals, and recently it was shown that ingestion of bLF inhibits the growth of adenomatous polyps in human patients. Here we review work which established bLF as an anti-carcinogenic agent in laboratory animals and the results of a clinical trial which demonstrated that bLF can reduce the risk of colon carcinogenesis in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available